Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 12 Issue: 3, March

Editorial [Hot Topic: Natural Products Triggering Biological Targets (Guest Editor: Francesco Epifano)]

Volume:12   Issue: 3
Pp: 287-287
Francesco Epifano
DOI: 10.2174/138945011794815239
Published on: 01 March, 2012

Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase

Volume:12   Issue: 3
Pp: 302-321
Alessandra Braca, Fabrizio Dal Piaz, Stefania Marzocco, Giuseppina Autore, Antonio Vassallo and Nunziatina De Tommasi
DOI: 10.2174/138945011794815284
Published on: 01 March, 2012

The Targets of Curcumin

Volume:12   Issue: 3
Pp: 332-347
Hongyu Zhou, Christopher S. Beevers and Shile Huang
DOI: 10.2174/138945011794815356
Published on: 01 March, 2012

Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs

Volume:12   Issue: 3
Pp: 348-356
Gonzalo Sanchez-Duffhues, Minh Q. Vo, Moises Perez, Marco A. Calzado, Santiago Moreno, Giovanni Appendino and Eduardo Munoz
DOI: 10.2174/138945011794815266
Published on: 01 March, 2012

Therapeutic and Diagnostic Applications of Nanoparticles

Volume:12   Issue: 3
Pp: 357-365
Mahmoud Youns, Jorg D. Hoheisel and Thomas Efferth
DOI: 10.2174/138945011794815257
Published on: 01 March, 2012

Auraptene: A Natural Biologically Active Compound with Multiple Targets

Volume:12   Issue: 3
Pp: 381-386
Salvatore Genovese and Francesco Epifano
DOI: 10.2174/138945011794815248
Published on: 01 March, 2012

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

Volume:12   Issue: 3
Pp: 387-391
Hans Carl Hasselbalch
DOI: 10.2174/138945011794815220
Published on: 01 March, 2012

Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives

Volume:12   Issue: 3
Pp: 392-419
Hans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, Morten Krogh Jensen and Jean-Jacques Kiladjian
DOI: 10.2174/138945011794815275
Published on: 01 March, 2012

Interferon alpha for Treatment of Chronic Myeloid Leukemia

Volume:12   Issue: 3
Pp: 420-428
Bengt Simonsson, Henrik Hjorth-Hansen, Ole Weis Bjerrum and Kimmo Porkka
DOI: 10.2174/138945011794815301
Published on: 01 March, 2012

Interferon Treatment in Patients with Hypereosinophilia

Volume:12   Issue: 3
Pp: 429-432
Ole Weis Bjerrum
DOI: 10.2174/138945011794815211
Published on: 01 March, 2012

Interferon-α Treatment in Systemic Mastocytosis

Volume:12   Issue: 3
Pp: 433-436
Ole Weis Bjerrum
DOI: 10.2174/138945011794815293
Published on: 01 March, 2012

Interferon-Alpha in the Treatment of Multiple Myeloma

Volume:12   Issue: 3
Pp: 437-446
Teh Liane Khoo, Annette Juul Vangsted, Douglas Joshua and John Gibson
DOI: 10.2174/138945011794815329
Published on: 01 March, 2012